Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
AXIL - AXIL Brands Inc. - Stock Price Chart
CompanyAXIL Brands Inc.
IndustryConsumer Electronics
Market Cap49.16MEPS (ttm)0.15
P/E57.22EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.76EPS next 5Y-
P/B5.61EPS Q/Q388.37%
Dividend-Sales Q/Q14.37%
Insider Own54.15%Inst Own0.01%
Insider Trans0.00%Inst Trans-70.58%
Short Float0.02%Earnings-
Analyst Recom-Target Price-
Avg Volume9.54K52W Range5.00 - 15.00
AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Alhambra, CA.
CRKN - Crown ElectroKinetics Corp - Stock Price Chart
CompanyCrown ElectroKinetics Corp
IndustrySpecialty Chemicals
Market Cap17.10MEPS (ttm)-19.44
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.53%
P/S21.12EPS next 5Y-
P/B0.92EPS Q/Q97.27%
Dividend-Sales Q/Q3000.00%
Insider Own0.03%Inst Own0.07%
Insider Trans0.00%Inst Trans0.48%
Short Float6.60%EarningsApr 01/b
Analyst Recom3.00Target Price90.00
Avg Volume165.13M52W Range0.04 - 8.93
Crown ElectroKinetics Corp. engages in the commercialization of electro kinetic technology for use in the smart glass market. It develops and sells optical switching film that can be embedded between glass or applied to the surface of glass or other rigid substrates such as acrylic, to electronically control opacity. The company was founded by Douglas B. Croxall and Timothy Koch on April 20, 2015 and is headquartered in Corvallis, OR.
BNAI - Brand Engagement Network Inc - Stock Price Chart
CompanyBrand Engagement Network Inc
IndustrySoftware - Infrastructure
Market Cap99.29MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.86EPS Q/Q-422.46%
Dividend-Sales Q/Q-
Insider Own56.44%Inst Own1.93%
Insider Trans0.00%Inst Trans-
Short Float4.25%EarningsMay 14/a
Analyst Recom-Target Price-
Avg Volume3.29M52W Range0.99 - 19.75
Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is headquartered in Jackson, WY.
OLB - OLB Group Inc - Stock Price Chart
TickerOLB [NASD]
CompanyOLB Group Inc
IndustrySoftware - Infrastructure
Market Cap4.70MEPS (ttm)-14.95
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-42.88%
P/S0.17EPS next 5Y-
P/B0.42EPS Q/Q21.32%
Dividend-Sales Q/Q-47.21%
Insider Own40.06%Inst Own3.33%
Insider Trans163.13%Inst Trans-68.57%
Short Float0.22%EarningsApr 15/b
Analyst Recom1.00Target Price30.00
Avg Volume38.29K52W Range2.81 - 11.70
The OLB Group, Inc. is a FinTech company, which focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. It operates through the Fintech Services and Bitcoin Mining Business segments. The Fintech Services segment provides integrated financial and transaction processing services to businesses throughout the United States. The company was founded by Ronny Yakov on November 18, 2004 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
YAKOV RONNYChairman and CEOJan 16 '24Buy0.77784,212600,0015,409,701Jan 19 01:57 PM
Smith Patrick GVice PresidentJan 16 '24Buy0.77392,106300,000642,929Jan 19 11:16 AM
YAKOV RONNYChairman and CEOJan 12 '24Option Exercise0.00420,001425,829,702Jan 26 06:02 PM
Smith Patrick GVice President - FinanceJan 12 '24Option Exercise0.00381,069381,023,998Jan 30 04:10 PM
YAKOV RONNYChairman and CEOJul 21 '23Buy0.998,1158,0524,625,489Dec 12 06:14 AM
AISP - Airship AI Holdings Inc - Stock Price Chart
CompanyAirship AI Holdings Inc
IndustrySoftware - Infrastructure
Market Cap100.51MEPS (ttm)0.65
P/E6.66EPS this Y69.70%
Forward P/E54.25EPS next Y180.00%
PEG-EPS past 5Y-
P/S8.17EPS next 5Y-
P/B-EPS Q/Q-4475.86%
Dividend-Sales Q/Q-
Insider Own54.03%Inst Own4.70%
Insider Trans0.48%Inst Trans23.09%
Short Float4.87%EarningsJun 25/b
Analyst Recom1.00Target Price12.00
Avg Volume2.40M52W Range1.34 - 14.32
Airship AI Holdings, Inc. engages in a video, sensor, and data management surveillance platform, that focuses on the provision of software services. Its products include Airship Acropolis OS, Airship Command, and Airship Outpost. The company was founded in 2003, and is headquartered in Redmond, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huang VictorCEO and Chairman of the BODJan 02 '24Buy1.4810,00014,80060,000Jan 02 08:20 PM
Huang VictorCEO and Chairman of the BODDec 29 '23Buy1.7310,00017,25050,000Jan 02 08:20 PM
Huang VictorCEO and Chairman of the BODDec 28 '23Buy2.0740,00082,86740,000Jan 02 08:20 PM
Byte Holdings LPDirector by DeputizationSep 20 '23Buy10.6370,555750,0008,662,868Sep 25 09:39 AM
Byte Holdings LPDirector by DeputizationAug 21 '23Buy10.57500,0005,285,0008,592,313Aug 21 04:30 PM
ZEO - Zeo Energy Corp. - Stock Price Chart
TickerZEO [NASD]
CompanyZeo Energy Corp.
Market Cap149.39MEPS (ttm)-1.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.66EPS next 5Y-
P/B-EPS Q/Q-1141.23%
Dividend-Sales Q/Q-
Insider Own93.99%Inst Own1.14%
Insider Trans0.00%Inst Trans4.63%
Short Float0.57%Earnings-
Analyst Recom-Target Price-
Avg Volume12.77K52W Range4.03 - 12.34
Zeo Energy Corp. is a vertically integrated provider of residential solar energy systems, other energy efficient equipment, and related services. The company is headquartered in New Port Richey, FL.
ZVSA - ZyVersa Therapeutics Inc - Stock Price Chart
CompanyZyVersa Therapeutics Inc
Market Cap3.34MEPS (ttm)-75.45
P/E-EPS this Y98.62%
Forward P/E-EPS next Y-206.98%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.30EPS Q/Q-1067.67%
Dividend-Sales Q/Q-
Insider Own1.06%Inst Own11.47%
Insider Trans0.00%Inst Trans-
Short Float0.47%EarningsMay 15/b
Analyst Recom1.00Target Price70.00
Avg Volume211.96K52W Range3.94 - 115.15
May-15-24 11:53PM ZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024 (InvestorPlace) -6.62%
08:35AM ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention (GlobeNewswire)
Apr-29-24 07:57AM ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer's Disease (GlobeNewswire) +15.63%
Apr-04-24 07:57AM ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes (GlobeNewswire)
Mar-25-24 08:17AM ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-18-24 07:57AM ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease (GlobeNewswire) +8.79%
Mar-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled Inflammation Illuminated, at Benzinga's Virtual Healthcare Summit 2024 on March 20, 2024 (GlobeNewswire)
Feb-29-24 07:57AM ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity (GlobeNewswire) +10.00%
Feb-28-24 07:57AM ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100's Rationale for Inhibiting ASC and ASC Specks to Attenuate Damaging Inflammation Associated with Various Conditions, Including Obesity and Its Complications (GlobeNewswire) -8.26%
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.
GUTS - Fractyl Health Inc. - Stock Price Chart
CompanyFractyl Health Inc.
Market Cap216.03MEPS (ttm)-
P/E-EPS this Y95.61%
Forward P/E-EPS next Y-28.39%
PEG-EPS past 5Y-126.07%
P/S-EPS next 5Y-
P/B2.57EPS Q/Q66.90%
Dividend-Sales Q/Q-
Insider Own58.50%Inst Own29.48%
Insider Trans5.52%Inst Trans-
Short Float14.96%EarningsMay 13/a
Analyst Recom1.00Target Price22.00
Avg Volume193.39K52W Range5.17 - 14.50
Today 06:00AM Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates (GlobeNewswire)
Jun-23-24 01:30PM Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva Single-Administration GLP-1 Pancreatic Gene Therapy in President's Select Oral Presentation at the American Diabetes Association's 84th Scientific Sessions (GlobeNewswire)
May-29-24 07:00AM Fractyl Health to Present New Preclinical Obesity Data from Rejuva Platform at the American Diabetes Association's 84th Scientific Sessions (GlobeNewswire)
May-20-24 06:00AM Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva at Digestive Disease Week 2024 (GlobeNewswire)
May-13-24 08:56PM GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024 (InvestorPlace) +8.52%
04:00PM Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
11:41AM Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes (MT Newswires)
06:00AM Fractyl Health Presents Clinical Update on Revita German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D) (GlobeNewswire)
May-08-24 06:00AM Fractyl Health to Present at BofA Securities 2024 Health Care Conference (GlobeNewswire)
May-07-24 06:00AM Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024 (GlobeNewswire)
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elia MarcDirectorFeb 06 '24Buy15.00466,6666,999,9901,856,117Feb 08 04:32 PM
CVF, LLC10% OwnerFeb 06 '24Buy15.00333,3334,999,9954,673,870Feb 06 08:39 PM
Mithril LP10% OwnerFeb 06 '24Buy15.00333,3334,999,9951,251,900Feb 08 04:35 PM
Royan AjayDirectorFeb 06 '24Buy15.00333,3334,999,9951,251,900Feb 08 04:37 PM
ARBK - Argo Blockchain Plc ADR - Stock Price Chart
CompanyArgo Blockchain Plc ADR
CountryUnited Kingdom
IndustryCapital Markets
Market Cap61.89MEPS (ttm)-0.57
P/E-EPS this Y-99.52%
Forward P/E-EPS next Y-21.72%
PEG-EPS past 5Y-18.79%
P/S0.98EPS next 5Y-
P/B7.99EPS Q/Q70.33%
Dividend-Sales Q/Q45.82%
Insider Own-Inst Own4.14%
Insider Trans-Inst Trans-7.92%
Short Float1.48%EarningsMay 23/a
Analyst Recom3.00Target Price1.25
Avg Volume352.43K52W Range0.94 - 4.45
Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.
RNXT - RenovoRx Inc - Stock Price Chart
CompanyRenovoRx Inc
Market Cap26.35MEPS (ttm)-0.72
P/E-EPS this Y63.13%
Forward P/E-EPS next Y-4.11%
PEG-EPS past 5Y-22.39%
P/S-EPS next 5Y-
P/B10.50EPS Q/Q79.91%
Dividend-Sales Q/Q-
Insider Own1.91%Inst Own1.38%
Insider Trans0.00%Inst Trans1.21%
Short Float0.26%EarningsMay 13
Analyst Recom1.00Target Price5.75
Avg Volume51.75K52W Range0.53 - 3.29
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nelms AngelaChief Operating OfficerOct 03 '23Buy1.051,1001,1511,100Oct 04 04:44 PM